eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
12.60
-0.17 (-1.35%)
Oct 16, 2025, 4:00 PM EDT - Market closed
eXoZymes Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
31
Market Cap
105.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 70.07K | 41.47K | 145.01% |
| Dec 31, 2022 | 28.60K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEXOZ News
- 16 days ago - Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees - Accesswire
- 2 months ago - eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today - Accesswire
- 2 months ago - eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST - Accesswire
- 2 months ago - eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity - Accesswire
- 3 months ago - eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months - Accesswire
- 4 months ago - eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing - Accesswire
- 5 months ago - eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast - Accesswire
- 5 months ago - eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today - Accesswire